These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31777048)

  • 1. Cefepime Dosing in Neonates: What is the Evidence?
    McDonald D; Shah P
    Am J Perinatol; 2021 Jun; 38(7):657-661. PubMed ID: 31777048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized Pharmacokinetic and Pharmacodynamic Evaluation of Every 8-Hour and 12-Hour Dosing Strategies of Vancomycin and Cefepime in Neurocritically ill Patients.
    Kassel LE; Van Matre ET; Foster CJ; Fish DN; Mueller SW; Sherman DS; Wempe MF; MacLaren R; Neumann RT; Kiser TH
    Pharmacotherapy; 2018 Sep; 38(9):921-934. PubMed ID: 29906310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of i.v. push administration on β-lactam pharmacodynamics.
    Butterfield-Cowper JM; Burgner K
    Am J Health Syst Pharm; 2017 May; 74(9):e170-e175. PubMed ID: 28438821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and Pharmacodynamics of Extended-Infusion Cefepime in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Prospective, Open-Label Study.
    Philpott CD; Droege CA; Droege ME; Healy DP; Courter JD; Ernst NE; Harger NJ; Foertsch MJ; Winter JB; Carter KE; Van Fleet SL; Athota K; Mueller EW
    Pharmacotherapy; 2019 Nov; 39(11):1066-1076. PubMed ID: 31549737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-lactam dosing strategies: Think before you push.
    Liu J; Rhodes NJ; Roberts JA; Pais GM; Turner B; Kiel PJ; Scheetz MH
    Int J Antimicrob Agents; 2020 Nov; 56(5):106151. PubMed ID: 32882430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Individualized Cefepime Dosing Strategy Using Population Pharmacokinetics.
    Mo Y; Shcherbakova N; Inman KL; Li WK; Kovalenko K; Rosenberg J; Orsini J; Truong J
    J Clin Pharmacol; 2022 Mar; 62(3):359-365. PubMed ID: 34542174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of Cefepime in Children on Extracorporeal Membrane Oxygenation: External Model Validation, Model Improvement and Dose Optimization.
    Thibault C; Moorthy GS; Vedar C; Naim MY; DiLiberto MA; Zuppa AF
    Pediatr Infect Dis J; 2022 Mar; 41(3):217-223. PubMed ID: 34817416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a cefepime shortage on dosing regimens and outcomes in hospitalized adults with febrile neutropenia.
    Haiduc M; Patel M; Walsh TL; Moffa MA; Bremmer DN
    J Oncol Pharm Pract; 2021 Mar; 27(2):297-304. PubMed ID: 32316878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating outcomes of alternative dosing strategies for cefepime: a qualitative systematic review.
    Burgess SV; Mabasa VH; Chow I; Ensom MH
    Ann Pharmacother; 2015 Mar; 49(3):311-22. PubMed ID: 25575975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of cefepime toxicodynamics: comprehensive examination of pharmacokinetic/pharmacodynamic targets for cefepime-induced neurotoxicity and evaluation of current dosing guidelines.
    Lau C; Marriott D; Schultz HB; Gould M; Andresen D; Wicha SG; Alffenaar JW; Penm J; Reuter SE
    Int J Antimicrob Agents; 2021 Dec; 58(6):106443. PubMed ID: 34551358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefepime dosing in the morbidly obese patient population.
    Rich BS; Keel R; Ho VP; Turbendian H; Afaneh CI; Dakin GF; Pomp A; Nicolau DP; Barie PS
    Obes Surg; 2012 Mar; 22(3):465-71. PubMed ID: 22249886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units.
    Roos JF; Bulitta J; Lipman J; Kirkpatrick CM
    J Antimicrob Chemother; 2006 Nov; 58(5):987-93. PubMed ID: 16943209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population Pharmacokinetics and Pharmacodynamic Target Attainment of Ampicillin in Neonates with Hypoxemic-Ischemic Encephalopathy in the Setting of Controlled Hypothermia.
    Cies JJ; Fugarolas KN; Moore WS; Mason RW; Menkiti OR
    Pharmacotherapy; 2017 Apr; 37(4):456-463. PubMed ID: 28226400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adequacy of high-dose cefepime regimen in febrile neutropenic patients with hematological malignancies.
    Sime FB; Roberts MS; Tiong IS; Gardner JH; Lehman S; Peake SL; Hahn U; Warner MS; Roberts JA
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5463-9. PubMed ID: 26124158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of cefepime in neonates with severe nosocomial infections.
    Lima-Rogel V; Medina-Rojas EL; Del Carmen Milán-Segovia R; Noyola DE; Nieto-Aguirre K; López-Delarosa A; Romano-Moreno S
    J Clin Pharm Ther; 2008 Jun; 33(3):295-306. PubMed ID: 18452417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacodynamics of cefepime in patients infected with Pseudomonas aeruginosa.
    Crandon JL; Bulik CC; Kuti JL; Nicolau DP
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1111-6. PubMed ID: 20038614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic/Pharmacodynamic Dosage Individualization of Cefepime in Critically Ill Patients: A Case Study.
    Goutelle S; Jay L; Boidin C; Cohen S; Bourguignon L; Bleyzac N; Wallet F; Vassal O; Friggeri A
    Ther Drug Monit; 2021 Aug; 43(4):451-454. PubMed ID: 33883521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefepime free minimum concentration to minimum inhibitory concentration (fCmin/MIC) ratio predicts clinical failure in patients with Gram-negative bacterial pneumonia.
    Aitken SL; Altshuler J; Guervil DJ; Hirsch EB; Ostrosky-Zeichner LL; Ericsson CD; Tam VH
    Int J Antimicrob Agents; 2015 May; 45(5):541-4. PubMed ID: 25665726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of five beta-lactam antibiotics against common nosocomial pathogens using the time above MIC at different creatinine clearances.
    Kays MB
    Pharmacotherapy; 1999 Dec; 19(12):1392-9. PubMed ID: 10600088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic outcomes of a simplified, weight-based, extended-interval gentamicin dosing protocol in critically ill neonates.
    Hoff DS; Wilcox RA; Tollefson LM; Lipnik PG; Commers AR; Liu M
    Pharmacotherapy; 2009 Nov; 29(11):1297-305. PubMed ID: 19857147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.